synthesi
matur
eukaryot
mrna
crucial
event
gene
express
follow
mrna
synthesi
eukaryot
mrna
undergo
seri
critic
modif
export
cytoplasm
translat
protein
process
event
includ
addit
cap
structur
terminu
splice
intron
edit
specif
nucleotid
acquisit
poli
tail
terminu
cap
structur
found
end
eukaryot
mrna
critic
splice
capproxim
intron
transport
mrna
nucleu
cytoplasm
stabil
translat
effici
mrna
synthesi
cap
structur
occur
cotranscript
nascent
mrna
involv
three
enzymat
reaction
first
rna
rtase
hydrolyz
nascent
premrna
gener
end
rna
guanylyltransferas
gtase
catalyz
twostep
reaction
initi
util
gtp
substrat
form
coval
enzymegmp
epg
intermedi
concomit
releas
pyrophosph
ppi
gmp
moieti
transfer
end
nascent
rna
transcript
second
step
reaction
form
gppprna
structur
final
use
sadenosylmethionin
substrat
rna
methyltransferas
catalyz
transfer
methyl
group
posit
guanin
produc
characterist
cap
structur
human
bifunct
rna
cap
enzym
catalyz
rtase
gtase
reaction
distinct
domain
separ
polypeptid
mediat
subsequ
methyl
import
cap
structur
rna
metabol
highlight
genet
analys
saccharomyc
cerevisia
show
triphosphatas
guanylyltransferas
methyltransferas
compon
cap
apparatu
essenti
cell
growth
nascent
mrna
cap
rapid
dynam
regul
cotranscript
process
subject
qualiti
control
transcript
initi
associ
rna
polymeras
ii
rna
pol
ii
carboxytermin
domain
ctd
ser
phosphoryl
recruit
cap
apparatu
nascent
mrna
rapidli
cap
nt
long
follow
rna
pol
ii
ctd
ser
phosphoryl
hce
dissoci
mrna
elong
messeng
rna
cap
repres
qualiti
control
checkpoint
uncap
rna
degrad
exonucleas
order
avoid
gener
uncap
mrna
like
translat
uncap
mrna
recogn
initi
factor
degrad
given
rna
pol
ii
synthes
base
per
second
entir
fate
unsuccess
cap
mrna
seal
within
second
stress
import
rapid
effici
mrna
cap
ratelimit
activ
cap
apparatu
twostep
pingpong
gtase
activ
gener
mechan
phosphoryltransf
involv
conform
chang
open
close
form
enzym
previous
solv
base
variou
gtase
crystal
structur
first
step
reaction
initi
bind
gtp
open
form
enzym
follow
closur
ctermin
oligomerbind
ob
fold
domain
ntermin
nucleotidyl
transferas
nt
domain
closur
stabil
interact
bound
nucleotid
residu
nt
ob
fold
domain
catalyt
activ
close
conform
gtp
substrat
hydrolyz
produc
enzymegmp
coval
intermedi
interact
bound
guanyl
ob
fold
domain
disrupt
upon
gtp
hydrolysi
lead
reopen
enzym
concomit
releas
pyrophosph
open
conform
expos
rnabind
site
therebi
allow
subsequ
transfer
gmp
moieti
onto
acceptor
rna
figur
summar
mechanist
structur
pathway
use
gtase
inhibitor
gtase
activ
identifi
recent
vitro
studi
shown
foscarnet
antivir
drug
target
dna
polymeras
human
cytomegaloviru
potent
inhibitor
gtase
reaction
inhibit
gtase
reaction
like
occur
bind
foscarnet
activ
site
enzym
account
analog
natur
pyrophosph
product
polymeras
rna
guanylyltransferas
reaction
intracellular
triphosphoryl
form
ribavirin
broadspectrum
antivir
nucleosid
analogu
also
inhibit
activ
viral
gtase
mechanist
studi
demonstr
ribavirin
triphosph
actual
use
substrat
viral
gtase
howev
rna
cap
ribavirin
rel
inert
methyl
viral
rna
methyltransferas
thu
result
mrna
stabl
effici
translat
viral
protein
ribavirin
pleiotrop
agent
also
inhibit
cellular
dehydrogenas
impdh
critic
metabol
nucleic
acid
precursor
enzym
catalyz
convers
inosin
monophosph
imp
xanthosin
monophosph
xmp
concomit
reduct
nad
via
coval
intermedi
exmp
convers
shown
ratelimit
step
de
novo
guanin
nucleotid
biosynthesi
reduct
intracellular
concentr
guanosin
key
factor
contribut
decreas
viral
replic
mizoribin
monophosph
mzp
anoth
compound
shown
specif
inhibit
cellular
impdh
mzp
fig
activ
metabolit
immunosuppress
prodrug
mizoribin
bredinin
nucleosid
analog
imidazol
class
origin
isol
eupenicillium
brefeldianum
crystallograph
studi
demonstr
bind
mzp
impdh
result
transit
state
analogu
complex
reminisc
exmp
intermedi
form
convers
imp
xmp
mzp
therefor
highli
potent
antagonist
inhibitor
impdh
block
prolifer
b
lymphocyt
use
de
novo
pathway
guanin
nucleotid
synthesi
almost
exclus
guanosin
nucleotid
deplet
impair
g
protein
coupl
receptor
transduct
cyclic
gmp
signal
ultim
result
interrupt
phase
cell
cycl
specif
inhibit
impdh
use
mizoribin
approv
japan
induct
mainten
immunosuppress
therapi
renal
transplant
sinc
ribavirin
triphosph
mzp
share
function
similar
investig
attract
possibl
mzp
could
also
inhibit
gtase
activ
human
rna
cap
enzym
hce
present
studi
demonstr
mzp
inhibit
format
rna
cap
structur
catalyz
hce
biolog
implic
inhibit
discuss
express
plasmid
contain
fulllength
hce
protein
amino
acid
gener
insert
correspond
cdna
nhei
xhoi
clone
site
plasmid
novagen
context
hce
protein
fuse
frame
ntermin
tag
express
protein
driven
rna
polymeras
promot
upon
transform
pethc
plasmid
escherichia
coli
cultur
grown
luriabertani
medium
contain
kanamycin
reach
induct
initi
isopropyl
iptg
ethanol
protein
express
allow
h
subsequ
procedur
perform
bacteria
harvest
centrifug
rpm
resuspend
ml
lysi
buffer
mm
trishcl
ph
mm
nacl
sucros
lysozym
triton
ad
prior
sonic
remov
insolubl
materi
centrifug
rpm
solubl
extract
appli
qiagen
column
protein
elut
stepwis
elut
buffer
mm
trishcl
ph
mm
nacl
glycerol
contain
mm
imidazol
polypeptid
composit
fraction
monitor
sdspage
recombin
hce
protein
recov
mm
imidazol
eluat
fraction
dialyz
buffer
c
mm
trishcl
ph
mm
nacl
mm
dithiothreitol
dtt
glycerol
supplement
mm
potassium
pyrophosph
ensur
homogen
nonguanylyl
enzym
protein
concentr
determin
biorad
dye
bind
method
store
amino
acid
correspond
hce
rtase
domain
correspond
hce
gtase
domain
also
express
separ
use
procedur
rna
substrat
nucleotid
synthes
maxiscript
kit
ambion
use
rna
polymeras
rna
substrat
purifi
denatur
polyacrylamid
gel
visual
ultraviolet
shadow
correspond
band
excis
elut
gel
overnight
incub
sd
ammonium
acet
rna
precipit
ethanol
quantit
spectrophotometri
altern
radiolabel
rna
substrat
also
synthes
ad
radiolabel
nucleotid
transcript
reaction
rna
substrat
also
synthes
subject
rna
hydrolysi
saccharomyc
cerevisia
rtase
reaction
carri
buffer
contain
mm
trishcl
ph
mm
mm
dtt
nmole
rna
min
rna
purifi
polyacrylamid
gel
excis
precipit
rna
substrat
quantifi
spectrophotometri
store
reaction
mixtur
contain
gtp
rna
hce
mm
trishcl
ph
mm
dtt
pyrophosphatas
roch
u
rnase
invitrogen
incub
min
reaction
stop
addit
phenolchloroform
load
dye
formamid
ad
aqueou
phase
submit
electrophoresi
denatur
polyacrylamid
gel
format
gppprna
quantifi
phosphorimag
reaction
mixtur
contain
mm
trishcl
ph
mm
dtt
rna
substrat
nt
hce
variou
concentr
mzp
indic
incub
min
reaction
stop
addit
formic
acid
aliquot
sampl
analyz
polyethyleneiminecellulos
thinlay
chromatographi
tlc
plate
develop
licl
formic
acid
releas
quantifi
scan
tlc
plate
phosphorimag
gtase
assay
conduct
describ
cap
rna
section
except
rna
use
substrat
altern
hce
substitut
either
vaccinia
viru
chlorella
viru
cerevisia
enzymegmp
complex
format
assay
carri
min
buffer
contain
gtp
hce
mm
trishcl
ph
mm
dtt
pyrophosphatas
roch
variou
concentr
mzp
indic
reaction
stop
addit
load
dye
mm
edta
sd
analyz
polyacrylamid
gel
contain
sd
format
radiolabel
hce
gmp
coval
complex
quantifi
phosphorimag
similar
experi
conduct
use
gtase
domain
hce
altern
equimolar
concentr
mzp
ad
reaction
addit
base
mm
buffer
format
enzymegmp
complex
initi
perform
min
buffer
contain
gtp
hce
mm
trishcl
ph
mm
dtt
pyrophosphatas
roch
u
rnase
invitrogen
transfer
reaction
initi
ad
rna
nt
final
concentr
variou
concentr
mzp
indic
sec
transfer
reaction
stop
addit
phenolchloroform
load
dye
formamid
ad
aqueou
phase
submit
electrophoresi
denatur
polyacrylamid
gel
format
gppprna
quantifi
phosphorimag
reaction
mixtur
contain
mm
trishcl
ph
mm
dtt
pyrophosphatas
roch
u
rnase
invitrogen
rna
substrat
nt
harbor
hce
incub
absenc
presenc
mm
gtp
mzp
h
reaction
ph
adjust
mm
naoac
follow
addit
nucleas
incub
min
digest
adjust
mm
trishcl
ph
digest
u
alkali
phosphatas
roch
min
reaction
product
analyz
thinlay
chromatographi
tlc
polyethyleneiminecellulos
plate
develop
ammonium
sulfat
hek
cell
cultur
dulbecco
minimum
essenti
medium
dmem
supplement
fetal
calf
serum
cell
transfect
accord
manufactur
instruct
use
genecellin
reagent
biocellchalleng
toulon
franc
day
confluent
cm
petri
dish
transfect
either
invitrogen
control
vector
construct
express
either
fulllength
hce
wildtyp
protein
amino
acid
fuse
ha
tag
hcewtha
gtase
defect
hce
mutant
fuse
ha
tag
green
fluoresc
protein
gfp
eighteen
hour
later
transfect
cell
seed
per
well
tissu
cultur
plate
h
mizoribin
sigma
ad
final
concentr
h
cell
submit
second
transfect
use
firefli
luciferas
encod
vector
promega
harvest
h
submit
luciferas
assay
promega
accord
manufactur
instruct
luciferas
activ
normal
untreat
cell
western
blot
perform
use
total
protein
extract
h
protein
separ
sdspage
transfer
onto
polyvinyliden
fluorid
membran
membran
block
incub
overnight
either
antiha
haprob
santa
cruz
biotechnolog
antigfp
sigmaaldrich
antiactin
antibodi
cell
signal
primari
monoclon
antibodi
follow
h
incub
hrpantimous
ge
healtcar
secondari
antibodi
revel
done
use
ecl
detect
perkinelm
exposur
xray
film
denvil
scientif
metazoan
initi
mrna
cap
bifunct
enzym
harbor
rtase
gtase
activ
peptid
order
evalu
inhibitori
potenc
mzp
human
cap
apparatu
hexahistidin
tag
fulllength
bifunct
hce
protein
amino
acid
express
e
coli
purifi
nickelagaros
chromatographi
ensur
purif
apoenzym
hce
dialyz
potassium
pyrophosph
magnesium
remov
residu
hcegmp
complex
hce
protein
predomin
polypeptid
purifi
fraction
fig
presenc
rna
gtp
magnesium
cofactor
fulllength
hce
also
shown
sequenti
hydrolyz
rna
substrat
transfer
gmp
moieti
gtp
substrat
onto
newli
rna
form
gppprna
cap
structur
fig
order
investig
mzp
could
inhibit
rna
cap
reaction
initi
address
impact
complet
rna
cap
reaction
rtasegtas
cold
rna
incub
presenc
hce
gtp
magnesium
increas
concentr
mzp
shown
figur
addit
increas
concentr
mzp
reaction
effici
prevent
format
radiolabel
cap
rna
mzp
inhibit
reaction
fig
ensur
inhibit
mzp
specif
reaction
perform
presenc
increas
concentr
gmp
chemic
relat
mzp
rna
cap
reaction
significantli
alter
presenc
increas
concentr
gmp
concentr
high
mm
reduc
rna
cap
fig
next
investig
suscept
rtase
domain
hce
mzp
inhibit
specif
monitor
effect
mzp
rtase
activ
rna
incub
hce
magnesium
rtase
activ
monitor
analysi
product
releas
radiolabel
rna
tlc
autoradiographi
data
indic
increas
concentr
mzp
affect
rtase
activ
mm
fig
note
similar
result
obtain
assay
perform
rtase
domain
hce
data
shown
gtase
reaction
twostep
pingpong
reaction
involv
format
coval
epg
intermedi
upon
gtp
hydrolysi
follow
transfer
gmp
moieti
onto
rna
initi
investig
inhibitori
potenti
mzp
complet
twostep
gtase
reaction
steadyst
condit
multipl
turnov
rna
gtp
magnesium
pyrophosphatas
variou
concentr
mzp
preincub
togeth
reaction
initi
addit
hce
concentr
mzp
result
decreas
format
radiolabel
cap
rna
fig
interestingli
experi
conduct
isol
gtase
domain
hce
activ
still
inhibit
mzp
albeit
decreas
potenc
fig
order
address
presenc
activ
rtase
domain
could
influenc
suscept
hce
gtase
domain
mzp
inhibit
gener
point
mutat
catalyt
cystein
rtase
domain
classic
phosphatas
core
motif
iv
hcxxgxxr
st
g
result
show
rtasedefect
fulllength
hce
mutant
display
similar
inhibit
profil
wildtyp
enzym
fig
consequ
conclud
gtase
reaction
repres
catalyt
step
display
highest
suscept
mzp
inhibit
synthesi
rna
cap
structur
next
set
identifi
step
gtase
reaction
suscept
mzp
inhibit
order
investig
inhibitori
potenc
mzp
hcegmp
complex
format
first
step
hce
incub
gtp
magnesium
increas
concentr
mzp
sinc
gtase
reaction
known
highli
inhibit
pyrophosph
product
pyrophosphatas
also
ad
reaction
order
drive
reaction
forward
format
epg
coval
complex
singl
turnov
condit
analyz
sdspage
quantifi
phosphorimag
seen
figur
increas
concentr
mzp
prevent
format
epg
complex
elev
concentr
mzp
concentr
mm
mzp
result
inhibit
hcegmp
complex
format
despit
low
millimolar
mzp
concentr
requir
prevent
epg
format
inhibit
due
magnesium
cofactor
sequestr
sinc
addit
equimolar
concentr
mzp
influenc
effect
data
shown
nevertheless
mzp
inhibit
epg
complex
format
weak
could
sole
respons
global
inhibitori
potenc
mzp
next
investig
second
step
gtase
reaction
could
impair
mzp
epg
complex
format
allow
initi
form
upon
incub
hce
excess
gtp
magnesium
pyrophosphatas
next
variou
concentr
mzp
cold
rna
ad
initi
transfer
gmp
moieti
onto
rna
singl
turnov
condit
seen
figur
data
indic
mzp
minor
impact
second
gtase
step
conclud
inhibit
step
contribut
significantli
gener
inhibit
effect
caus
mzp
quantit
analysi
mzp
inhibit
complet
gtase
reaction
first
step
alon
conduct
format
gppprna
structur
epg
coval
complex
monitor
function
gtp
concentr
presenc
increas
concentr
mzp
mzp
concentr
impact
maxim
veloc
epg
format
gtase
first
step
suggest
competit
mechan
inhibit
fig
interestingli
complet
gtase
reaction
km
appear
independ
inhibitor
concentr
would
suggest
noncompetit
mechan
inhibit
fig
note
hce
abl
use
mzp
substrat
transfer
onto
radiolabel
acceptor
rna
form
atyp
cap
structur
fig
result
highlight
potenti
differ
mechan
action
mzp
weak
inhibit
epg
format
appear
competit
global
inhibit
seem
noncompetit
later
rais
possibl
mzp
could
primarili
bind
alloster
bind
site
order
investig
mzp
specif
inhibit
hce
gain
addit
insight
degre
conserv
main
mzp
bind
site
conduct
wide
array
gtase
inhibit
studi
mammalian
vaccinia
viru
gtase
saccharomyc
cerevisia
gtase
gtase
chlorella
viru
submit
mzp
inhibit
complet
gtase
reaction
epg
format
gtase
first
step
compar
hce
gtase
show
reduc
suscept
mzp
inhibit
complet
gtase
reaction
differ
rang
gtase
mammalian
vaccinia
viru
chlorella
viru
yeast
cerevisia
mm
fig
mzp
also
inhibit
epg
format
gtase
assess
albeit
smaller
variat
fig
human
vaccinia
viru
gtase
hce
valu
mm
chlorella
viru
gtase
present
mm
yeast
gtase
seem
slightli
less
affect
mzp
unlik
complet
gtase
reaction
low
potenc
inhibit
epg
format
mzp
fairli
similar
gtase
assess
result
support
hypothesi
inhibit
hcegmp
complex
mzp
could
account
minor
contribut
complet
gtase
activ
inhibit
rais
possibl
conform
chang
hindranc
could
mechan
action
mzp
inhibit
hce
hypothesi
investig
discuss
next
set
investig
vitro
inhibitori
potenc
mzp
hce
could
translat
inhibit
cap
apparatu
live
cell
monitor
cap
effici
mammalian
cell
great
challeng
rna
qualiti
control
system
ensur
unsuccess
cap
mrna
rapidli
degrad
net
result
cap
inhibit
would
lead
uncap
mrna
accumul
rather
global
decreas
matur
mrna
potenti
allow
indirectli
evalu
abil
mzp
inhibit
rna
cap
monitor
transcript
translat
report
gene
control
environ
averag
mrna
transcrib
everi
min
halflif
hour
translat
time
per
hour
yield
averag
protein
life
span
give
nearli
order
magnitud
amplif
everi
cap
event
provid
sensit
assay
attempt
rescu
cap
inhibit
induc
mzp
chose
four
ident
human
embryon
kidney
hek
cell
line
diverg
overexpress
hcewtha
gtase
defect
mutant
gfp
protein
fig
unlik
hcewtha
might
slightli
toxic
neg
domin
effect
would
explain
lower
overexpress
nevertheless
overexpress
mamalien
cell
easili
detect
activ
stabil
report
gene
firefli
luciferas
influenc
high
concentr
hce
fig
mizoribin
prodrug
ad
final
concentr
four
cell
line
report
gene
express
initi
upon
transfect
vector
bear
firefli
luciferas
report
gene
control
rna
pol
ii
promot
luminesc
quantif
report
level
perform
h
report
protein
express
fig
result
indic
cell
treat
mizoribin
show
global
reduct
protein
express
like
due
partial
gtp
deplet
induc
impdh
inhibit
interestingli
translat
report
gene
partial
rescu
cell
overexpress
hcewtha
compar
gfp
control
cell
presenc
mizoribin
cell
overexpress
hcewtha
maintain
significantli
higher
report
gene
translat
rate
compar
cell
line
harbor
function
cap
apparatu
fig
although
experi
allow
precis
quantif
cap
inhibit
demonstr
overexpress
activ
cap
apparatu
human
cell
partial
abl
rescu
mizoribineinduc
phenotyp
report
gene
depend
cap
structur
proper
transcript
translat
studi
provid
first
biochem
evid
mizoribin
monophosph
directli
inhibit
human
cap
enzym
abil
mzp
inhibit
purifi
rna
cap
enzym
previous
document
implic
understand
catalyt
mechan
rna
cap
enzym
result
indic
overal
gtase
reaction
inhibit
mzp
hce
bifunct
protein
harbor
rtase
gtase
activ
presenc
mzp
rtase
activ
appear
rel
unaffect
gtase
activ
inhibit
indic
gtase
activ
main
target
mzp
inhibit
gtase
catalysi
twostep
reaction
interestingli
inhibit
complet
gtase
reaction
mzp
could
explain
complet
inhibit
individu
step
gmp
transfer
onto
acceptor
rna
second
step
contribut
significantli
gener
inhibit
effect
caus
mzp
epg
format
first
step
inhibit
mzp
higher
complet
gtase
reaction
weak
inhibit
led
us
hypothes
two
distinct
mzp
bind
site
could
present
hce
main
bind
site
respons
drug
inhibitori
potenc
specul
alloster
discuss
second
would
activ
site
believ
bind
mzp
lower
affin
like
due
drug
chemic
similar
gmp
weak
bind
mzp
activ
site
would
coher
epg
complex
format
competit
inhibit
mzp
silico
dock
mzp
highli
conserv
activ
site
open
conform
homolog
model
hce
gtase
domain
provid
addit
inform
mechan
mzp
bind
site
fig
tabl
mzp
appear
coordin
conserv
amino
acid
would
therebi
explain
low
inhibit
specif
toward
variou
gtase
fig
nevertheless
mechan
inhibit
enzymegmp
complex
mediat
weak
bind
mzp
activ
site
fundament
differ
weaker
mechan
complet
gtase
inhibit
complet
gtase
catalyt
round
impli
format
epg
intermedi
complex
transfer
gmp
moieti
acceptor
rna
also
involv
complex
conform
chang
ob
fold
domain
lean
toward
away
nt
domain
mzp
could
bind
hce
block
conform
chang
possibl
stabil
close
conform
therebi
prevent
reopen
protein
upon
gtp
hydrolysi
hypothesi
would
like
impli
alloster
mzp
bind
site
interestingli
kinet
studi
although
perform
steadyst
condit
point
toward
noncompetit
mechan
inhibit
would
indic
mzp
bind
elsewher
activ
site
also
coher
inabl
mzp
use
substrat
transfer
onto
acceptor
rna
despit
high
degre
conserv
among
specif
famili
nucleotidyltransferas
mzp
harbor
gain
specif
hce
compar
gtase
result
addit
support
presenc
alloster
mzp
bind
pocket
oddli
enough
lone
gtase
domain
hce
less
suscept
mzp
inhibit
fulllength
hce
evid
support
presenc
alloster
site
also
provid
addit
inform
local
hce
tempt
specul
mzp
could
bind
near
ntermin
gtase
domain
close
rtasegtas
interdomain
region
interact
rtase
gtase
domain
sinc
abolit
rtase
domain
reduc
hce
mzp
suscept
order
gain
addit
detail
mzp
main
bind
site
molecular
dock
could
use
unfortun
structur
rtase
gtase
domain
separ
avail
structur
fulllength
protein
still
avail
nevertheless
ran
molecular
dock
experi
mzp
gtase
domain
hce
lack
rtase
domain
predict
particip
mzp
bind
moder
flexibl
ntermin
domain
introduc
structur
incertitud
allow
definit
conclus
reach
interest
note
preliminari
experi
mzp
favor
dock
ntermin
region
hce
gtase
near
rtasegtas
interdomain
togeth
result
reveal
mzp
inhibit
hce
gtase
activ
specif
comparison
gtase
although
work
yet
requir
confirm
hypothesi
result
rais
possibl
gtase
inhibit
could
mediat
conform
chang
hindranc
upon
bind
mzp
alloster
bind
site
specul
resid
near
rtasegtas
interdomain
nevertheless
mizoribin
one
first
compound
demonstr
certain
degre
specif
toward
singl
gtase
despit
high
degre
conserv
crucial
famili
enzym
mzp
display
higher
vitro
inhibit
potenc
gtase
reaction
comparison
complet
rna
cap
reaction
rtasegtas
may
simpli
due
experiment
condit
mm
low
nucleotid
triphosph
concentr
rtase
activ
hce
partial
inhibit
free
becom
ratelimit
step
howev
cellulo
rtase
harbor
higher
turnov
rate
gtase
catalyz
limit
step
rna
cap
cellular
context
expect
effici
mzp
dictat
sole
interact
gtase
histor
gtase
inhibitor
develop
neither
scientif
tool
therapeut
agent
recent
howev
novel
gtase
inhibitor
discov
includ
alloster
inhibitor
mycophenol
acid
pyrophosph
analog
foscarnet
act
product
inhibitor
ribavirin
triphosph
gtp
analog
transfer
acceptor
rna
gtase
lead
stabl
ineffici
translat
pseudocap
rna
current
studi
identifi
mzp
novel
alloster
gtase
inhibitor
specul
block
crucial
conform
chang
gtase
activ
ratelimit
step
essenti
cap
apparatu
gtase
inhibitor
promis
lead
candid
develop
novel
select
cap
inhibitor
lead
way
new
class
anticanc
antifung
antivir
drug
biolog
relev
present
find
numer
studi
demonstr
potenc
mzp
inhibit
cellular
impdh
lower
intracellular
guanosin
nucleotid
pool
therebi
limit
cell
growth
none
address
impact
cap
apparatu
monitor
cap
effici
live
cell
great
challeng
cellular
qualiti
control
machineri
degrad
unsuccess
cap
mrna
sinc
proper
cap
crucial
mrna
transcript
export
stabil
translat
possibl
monitor
cap
effici
base
translat
report
protein
order
evalu
mzp
could
impair
cellulo
cap
monitor
indirect
impact
translat
firefli
luciferas
report
gene
cellular
protein
level
dictat
cap
effici
select
cellular
model
variabl
unrel
cap
constant
cell
origin
popul
trasfect
order
overexpress
either
activ
hcewtha
gtasedefect
mutant
gfp
control
protein
protein
control
vector
submit
concentr
mizoribin
cell
line
treat
mizoribin
show
global
reduct
report
protein
express
compar
untreat
cell
expect
effect
like
due
partial
guanosin
pool
deplet
induc
impdh
inhibit
interestingli
reduct
transcript
translat
report
significantli
less
sever
cell
overexpress
hcewtha
mizoribin
concentr
abil
hcewtha
overexpress
partial
rescu
luciferas
express
presenc
mizoribin
demonstr
hce
one
mizoribin
pharmacolog
target
furthermor
inabl
gtase
defect
mutant
rescu
report
express
mizoribin
treatment
demonstr
agreement
vitro
result
cellular
context
gtase
activ
hce
target
mzp
although
indirect
strong
evid
mizoribin
abl
impair
cap
cellular
environ
expect
cap
could
fulli
inhibit
cellulo
mizoribin
concentr
approxim
vitro
despit
oral
bioavail
underli
membran
permeabl
low
bind
serum
protein
mizoribin
expect
reach
intracellular
concentr
higher
notic
effect
mizoribin
cellular
cap
howev
greater
anticip
hypothes
competit
hce
nascent
mrna
end
could
explain
potenc
mzp
cellulo
slow
inhibit
cap
activ
could
suffici
shift
balanc
toward
qualiti
control
takeov
degrad
reduc
downstream
protein
express
exact
contribut
cap
apparatu
inhibit
global
mizoribin
mechan
action
question
yet
address
immunosuppress
effect
mizoribin
tcell
mainli
mediat
gtp
deplet
block
tcell
prolifer
also
promot
tcell
apoptosi
might
exacerb
reduct
mrna
cap
downstream
capdepend
translat
studi
clearli
demonstr
therapeut
agent
mizoribin
monophosph
inhibit
human
rna
guanylyltransferas
vitro
impair
mrna
cap
cellulo
